CROSS COUNTRY HEALTHCARE INC
CCRNDrugs in Pipeline
8
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How CCRN's past catalysts played out
Chloroprocaine HCl 2%
Axillary Nerve Block
Chloroprocaine 3% eye gel
Local Anesthetic
rhNGF 20 µg/mL
Dry Eye Syndrome
RP101
Dry Eye Syndromes
Paracetamol 3%
Phase 1: Pain Management
dimiracetam
Neuropathy
30 mg Paracetamol 3% (1 mL)
Pain, Postoperative
Chloroprocaine HCl 1%
Short Duration Lower Limb Surgery Via Spinal Anaesthesia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Chloroprocaine HCl 2% | Phase 3 | Axillary Nerve Block | - | - |
Chloroprocaine 3% eye gel | Phase 3 | Local Anesthetic | - | - |
rhNGF 20 µg/mL | Phase 2 | Dry Eye Syndrome | - | - |
RP101 | Phase 2 | Dry Eye Syndromes | - | - |
Paracetamol 3% | Phase 2 | Phase 1: Pain Management | - | - |
dimiracetam | Phase 2 | Neuropathy | - | - |
30 mg Paracetamol 3% (1 mL) | Phase 2 | Pain, Postoperative | - | - |
Chloroprocaine HCl 1% | Phase 2 | Short Duration Lower Limb Surgery Via Spinal Anaesthesia | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in CROSS COUNTRY HEALTHCARE INC's drug pipeline?→
CatalystAlert tracks 8 drug candidates in CROSS COUNTRY HEALTHCARE INC's (CCRN) pipeline across Phase 3, Phase 2. Its lead program is Chloroprocaine HCl 2% (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CROSS COUNTRY HEALTHCARE INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for CROSS COUNTRY HEALTHCARE INC (CCRN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CCRN biotech catalysts?→
Add CCRN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CROSS COUNTRY HEALTHCARE INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.